IMA Q2 2025 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$45,000

Operating Income

-$9M

Net Income

-$3M

EPS (Diluted)

$-0.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$458,000

Balance Sheet

Total Assets

$126M

Total Liabilities

$10M

Stockholders' Equity

$116M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$45,000	-$400,000	+88.8%
Operating Income	-$9M	-$16M	+44.7%
Net Income	-$3M	-$14M	+79.8%